The medical devices sector is typified by frequent change and innovation, in response to problems and issues faced by the healthcare industry. As a result, the sector has seen the emergence of several start-up medtech companies offering disruptive, cutting-edge solutions. Most of these are private companies, where data such as revenue is frequently not disclosed. National estimates for QXMedical sales in the US from 2016 to 2022, as well as year-on-year growth rates, can be viewed in GlobalData’s micro revenue report. Buy the report here.
QXMedical designs and develops medical equipment that specializes in minimally invasive intervention devices for coronary, peripheral, and endovascular procedures. In endovascular interventions, the company offers an EVAR balloon catheter, Xpheres microspheres, and Occlusion balloon catheter. For coronary and vascular interventions, it provides boosting catheters. In emergency and trauma care, the company provides SVC tears or REBOA (Resuscitative Endovascular Balloon Occlusion of the Aorta). QXMedical is headquartered in Saint Paul, Minnesota, the US.
The key metrics of QXMedical related to marketed and pipeline products, ongoing clinical trials, active jobs and publications from 2022 are shown below:
As QXMedical is a privately held company, it is not required to disclose its financial information and there is no stock listed on an exchange. GlobalData has access to a proprietary data set containing invoice data from over 2,600 healthcare institutions in the US and is therefore able to use estimations of a company’s revenue and growth to value private companies such as QXMedical.
For a detailed understanding of the performance of QXMedical, buy the report here.